A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety, tolerability and activity of
VAX014 for Instillation (VAX014) in patients with low-grade Non-Muscle Invasive Bladder
Cancer (NMIBC). VAX014 is a targeted oncolytic agent designed to kill tumor cells following
instillation into the urinary bladder.